article_metadata: Amy E Goodman Lilit Karapetyan Melissa Pugliano-Mauro Joshua E Levenson Jason J Luke
article_metadata: 10.3389/fimmu.2021.660795
article_metadata: Front Immunol
article_metadata: 2021 Mar 22;12:660795.
article_metadata: biomarkers case report genomics immune-related adverse events immunotherapy transplant
article_metadata: CC BY
article_metadata: https://pubmed.ncbi.nlm.nih.gov/33828564/
article_metadata: Allografts Antibodies, Monoclonal, Humanized / therapeutic use Antineoplastic Agents, Immunological / therapeutic use Heart Melanoma / drug therapy Melanoma / secondary Programmed Cell Death 1 Receptor / antagonists & inhibitors
article_metadata: Allografts Antibodies, Monoclonal, Humanized / therapeutic use Antineoplastic Agents, Immunological / therapeutic use Heart Melanoma / drug therapy Melanoma / secondary Programmed Cell Death 1 Receptor / antagonists & inhibitors Case Reports Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S. Aged Antibodies, Monoclonal, Humanized / administration & dosage Antineoplastic Agents, Immunological / administration & dosage Humans Immune Checkpoint Inhibitors / therapeutic use Immunotherapy Male Melanoma / diagnostic imaging Tomography, X-Ray Computed Transplant Recipients Antibodies, Monoclonal, Humanized Antineoplastic Agents, Immunological Immune Checkpoint Inhibitors Programmed Cell Death 1 Receptor pembrolizumab
article_metadata: PMC8019780
article_metadata: 33828564
article_metadata: Case Report: Single Dose Anti-PD1 in a Patient With Metastatic Melanoma and Cardiac Allograft
article_metadata: 2021